Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial. [PDF]
Yu J +15 more
europepmc +1 more source
Addition of granulocyte macrophage colony stimulating factor (GM-CSF) during in vitro oocyte maturation improves embryo development in a mouse model of advanced maternal age. [PDF]
Saini A, McPherson NO, Nottle MB.
europepmc +1 more source
Nocardia Infection in Patients With Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies: A Prospective Multicenter French Study. [PDF]
Kerdiles T +23 more
europepmc +1 more source
Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23 [PDF]
Hapel, A J, Hume, D A, Warren, H S
core
Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients [Letter]. [PDF]
Yusuf S.
europepmc +1 more source
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia. [PDF]
Farmand S +8 more
europepmc +1 more source
Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients. [PDF]
Zhang X, Tao J, Gong S, Yu X, Shao S.
europepmc +1 more source
Efficacy and safety of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel in treating second- or third-degree burn wounds in children: a systematic review and meta-analysis. [PDF]
Hu N, Wang Y, Galfo M, Qi H.
europepmc +1 more source
Granulocyte- Macrophage Colony-Stimulating Factor Reverses Immunosuppression Acutely Following a Traumatic Brain Injury and Hemorrhage Polytrauma in a Juvenile Male Rat Model. [PDF]
Sribnick EA, Warner T, Hall MW.
europepmc +1 more source
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial. [PDF]
Ni J +9 more
europepmc +1 more source

